Literature DB >> 25156689

Educational paper: Pathogenesis of infantile haemangioma, an update 2014 (part I).

Sherief R Janmohamed1, Gerard C Madern, Peter C J de Laat, Arnold P Oranje.   

Abstract

UNLABELLED: Infantile haemangioma (IH) is the most frequent childhood tumour. Although it is benign and self-limiting, severe complications can arise due to localisation and fast tumour growth. Management and therapy of IH has changed greatly after 2008 with propranolol. However, the pathogenesis remains elusive. This update provides an overview of all possible mechanisms currently considered. We discuss the possibility that several mechanisms act together, although local hypoxia seems to be important. Clinically, in about half of the cases, an IH is preceded by an anaemic macula (local ischaemia) or a so-called precursor lesion. Laboratory findings indicate stabilisation and an increased transcription activity of hypoxia-inducible factor 1 alpha (HIF1α), leading to up-regulation of its downstream target genes (such as vascular endothelial growth factor (VEGF)), which normally occurs in cases of hypoxia.
CONCLUSION: Three main hypotheses have been proposed, namely (1) the theory of tissue hypoxia, (2) the theory of embolization of placental endothelial cells and (3) the theory of increased angiogenic and vasculogenic activity.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25156689     DOI: 10.1007/s00431-014-2403-6

Source DB:  PubMed          Journal:  Eur J Pediatr        ISSN: 0340-6199            Impact factor:   3.183


  54 in total

1.  Characteristics of infantile hemangiomas as clues to pathogenesis: does hypoxia connect the dots?

Authors:  Beth A Drolet; Ilona J Frieden
Journal:  Arch Dermatol       Date:  2010-11

2.  Placental hypoxia and neonatal haemangioma: clinical and histological observations.

Authors:  V Colonna; L Resta; A Napoli; E Bonifazi
Journal:  Br J Dermatol       Date:  2009-10-26       Impact factor: 9.302

3.  GLUT-1: an extra diagnostic tool to differentiate between haemangiomas and vascular malformations.

Authors:  J Leon-Villapalos; K Wolfe; L Kangesu
Journal:  Br J Plast Surg       Date:  2005-04

Review 4.  Update on vascular tumors of infancy.

Authors:  Robert Sidbury
Journal:  Curr Opin Pediatr       Date:  2010-08       Impact factor: 2.856

5.  The HIF-2alpha/VEGF pathway activation in cutaneous capillary haemangiomas.

Authors:  Alexandra Giatromanolaki; Vasiliki Arvanitidou; Athanasios Hatzimichael; Constantinos Simopoulos; Efthimios Sivridis
Journal:  Pathology       Date:  2005-04       Impact factor: 5.306

6.  Hypoxia-induced mediators of stem/progenitor cell trafficking are increased in children with hemangioma.

Authors:  Mark E Kleinman; Matthew R Greives; Samara S Churgin; Keith M Blechman; Eric I Chang; Daniel J Ceradini; Oren M Tepper; Geoffrey C Gurtner
Journal:  Arterioscler Thromb Vasc Biol       Date:  2007-09-13       Impact factor: 8.311

7.  Rapamycin inhibits proliferation of hemangioma endothelial cells by reducing HIF-1-dependent expression of VEGF.

Authors:  Damian Medici; Bjorn R Olsen
Journal:  PLoS One       Date:  2012-08-10       Impact factor: 3.240

8.  A novel hypoxia-inducible factor-independent hypoxic response regulating mammalian target of rapamycin and its targets.

Authors:  Andrew M Arsham; Jessica J Howell; M Celeste Simon
Journal:  J Biol Chem       Date:  2003-05-30       Impact factor: 5.157

Review 9.  Pathogenesis of infantile haemangioma: new molecular and cellular insights.

Authors:  Matthew R Ritter; Ross A Butschek; Martin Friedlander; Sheila F Friedlander
Journal:  Expert Rev Mol Med       Date:  2007-11-29       Impact factor: 5.600

Review 10.  Infantile hemangioma: challenges, new insights, and therapeutic promise.

Authors:  Eileen Boye; Masatoshi Jinnin; Bjorn R Olsen
Journal:  J Craniofac Surg       Date:  2009-03       Impact factor: 1.046

View more
  5 in total

Review 1.  Efficacy and adverse effects of oral propranolol in infantile hemangioma: a meta-analysis of comparative studies.

Authors:  Hao Yang; Dong-Lai Hu; Qiang Shu; Xiao-Dong Guo
Journal:  World J Pediatr       Date:  2019-07-24       Impact factor: 2.764

Review 2.  Treatment of infantile haemangiomas: recommendations of a European expert group.

Authors:  Peter H Hoeger; John I Harper; Eulalia Baselga; Damien Bonnet; Laurence M Boon; Marta Ciofi Degli Atti; Maya El Hachem; Arnold P Oranje; Agneta Troilius Rubin; Lisa Weibel; Christine Léauté-Labrèze
Journal:  Eur J Pediatr       Date:  2015-05-29       Impact factor: 3.183

3.  Association of Infantile Hemangiomas and Retinopathy of Prematurity: Analysis of the Multicenter KID.

Authors:  Nilesh Dankhara; Renjithkumar Kalikkot Thekkeveedu; Jaimin Patel; Jagdish Desai
Journal:  Biomed Hub       Date:  2022-01-31

4.  15,16-dihydrotanshinone I inhibits EOMA cells proliferation by interfering in posttranscriptional processing of hypoxia-inducible factor 1.

Authors:  Peiwen Duan; Yingying Huang; Kai Chen; Cheng Cheng; Zhixiang Wu; Yeming Wu
Journal:  Int J Med Sci       Date:  2021-07-11       Impact factor: 3.738

5.  The Effect of Oral Propranolol versus Oral Corticosteroids in Management of Pediatric Hemangiomas.

Authors:  Adil Ali; Umme Aiman; Mohd Azam Haseen; Mohd Altaf Mir; Imran Ghani; Ragya Bharadwaj; Mohd Yaseen
Journal:  World J Plast Surg       Date:  2018-01
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.